Gossamer Bio, Inc. (SWB:4GB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Faheem Hasnain Other companies: Aspen Neuroscience, Inc. (Aspen Executive Chairman · Since at least Nov 2, 2026); Kura Oncology, Inc. (Lead Independent Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Somaxon Pharmaceuticals Inc (Director · Sep 16, 2010 – Dec 31, 2012 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past) | Co-Founder, Chairman, and Chief Executive Officer · Since at least Feb 7, 2019 |
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · Feb 7, 2019 – Jun 8, 2023 · Past |
| Sheila Gujrathi Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past) | President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past |
| Otello Stampacchia Other companies: Windward Bio Group AG (Founder & Managing Director, Omega Fund Management, LLC · Since at least Nov 16, 2026); ImageneBio, Inc. (Director · Since at least Mar 25, 2021); Omega Alpha SPAC (Chief Executive Officer, Director · Jan 6, 2021 – Jan 11, 2021 · Past); Kronos Bio Inc (Director · Oct 8, 2020 – Jun 22, 2022 · Past); Morphic Holding Inc (Director · Jun 26, 2019 – Apr 29, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Nov 19, 2021 · Past) | Director · Feb 7, 2019 – Sep 10, 2019 · Past |
| Jakob Dupont Other companies: Bolt Biotherapeutics, Inc. (Director · Since at least Sep 3, 2024); Pyxis Oncology, Inc. (Director · Since at least Aug 23, 2023); Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Atara Biotherapeutics, Inc. (EVP, Head of R&D · May 14, 2020 – Mar 2, 2023 · Past); OncoMed Pharmaceuticals Inc (SVP & Chief Medical Officer · Jul 17, 2013 – Oct 9, 2016 · Past) | Chief Medical Officer · Feb 7, 2019 – Feb 14, 2020 · Past |
| Thomas Daniel Other companies: Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past); Larimar Therapeutics, Inc. (Director · Mar 3, 2016 – May 12, 2021 · Past); Juno Therapeutics Inc (Director · Aug 11, 2015 – Mar 5, 2018 · Past); Epizyme Inc (Director · May 30, 2013 – May 30, 2013 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past) | Director · Since at least Feb 7, 2019 |
| Greg Ciongoli Other companies: Theravance Biopharma, Inc. (Director · Since at least Nov 4, 2026); Regenxbio Inc. (Independent Board Member · Since at least Aug 25, 2026); Zymeworks Inc. (Director · Since at least Jan 12, 2026); Atara Biotherapeutics, Inc. (Director · Since at least Sep 3, 2025) | Director · Since at least Sep 16, 2026 |
| Renée Galá Other companies: DexCom, Inc. (Director · Since at least Mar 6, 2025); Jazz Pharmaceuticals plc (President & CEO, Director · Since at least Mar 16, 2020); Corcept Therapeutics Incorporated (Director · Mar 6, 2018 – Aug 20, 2018 · Past); Theravance Biopharma, Inc. (SVP, Chief Financial Officer · Nov 20, 2017 – Nov 20, 2018 · Past) | Director · Feb 7, 2019 – Jun 8, 2023 · Past |
| Gregory Austin Ciongoli Other companies: Regenxbio Inc. (Director · Since at least Aug 25, 2026); Zymeworks Inc. (Director · Since at least Aug 10, 2025); Atara Biotherapeutics, Inc. (Director · Since at least Sep 3, 2024) | Director · Since at least Sep 16, 2026 |
| Russell J. Cox Other companies: Immunic, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 11, 2019 · Past); Spyre Therapeutics, Inc. (Director · Apr 6, 2016 – Jun 22, 2023 · Past); Jazz Pharmaceuticals plc (EVP & COO · Feb 8, 2011 – Dec 11, 2017 · Past) | Director · Since at least Feb 7, 2019 |
| Sandra Milligan Other companies: Spyre Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least May 14, 2024); Aspira Women's Health Inc. (Interim CEO & President · Apr 1, 2024 – Dec 31, 2024 · Past); Organon & Co. (Head of Research & Development · Jun 2, 2021 – May 4, 2023 · Past) | Director · Since at least Jun 10, 2021 |
| John Quisel Other companies: Disc Medicine, Inc. (Chief Executive Officer · Since at least Dec 29, 2022); Acceleron Pharma Inc (EVP, Chief Business Officer · Sep 18, 2013 – Jan 2, 2020 · Past) | Director · Since at least Nov 28, 2023 |
| Bryan Giraudo Other companies: Protagonist Therapeutics, Inc. (Director · Since at least May 15, 2018) | Chief Operating Officer & Chief Financial Officer · Since at least Feb 7, 2019 |
| Caryn Peterson Other companies: Aspen Neuroscience, Inc. (Chief Development Officer, Gossamer · Since at least Nov 5, 2026) | Chief Development Officer · Since at least Apr 16, 2021 |
| Christian Waage Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 5, 2026) | Executive Vice President, Technical Operations & General Counsel · Since at least Nov 5, 2026 |
| Luisa Salter-Cid Other companies: Jounce Therapeutics Inc (Director · Feb 10, 2021 – May 3, 2023 · Past) | Chief Scientific Officer · Feb 7, 2019 – Mar 23, 2021 · Past |
| Waage Christian Other companies: Heron Therapeutics, Inc. (Director · Since at least Jan 19, 2024) | EVP, Tech Ops and Admin · Since at least Nov 20, 2023 |
| Bob Smith | Chief Commercial Officer · Since at least Nov 4, 2026 |
| Conor O’Donovan | Senior Vice President, Regulatory Affairs · Since at least Nov 5, 2026 |
| Deanna Weber | Executive Vice President, Human Resources · Since at least Nov 5, 2026 |
| Jeanine Anthony | Senior Vice President, Marketing · Since at least Nov 5, 2026 |
| Jean-Marie Bruey | Senior Vice President, Translational Medicine and Research · Since at least Nov 5, 2026 |
| Kelly Dawson | Senior Vice President, Program Team Lead · Since at least Nov 5, 2026 |
| Laura Carter | Chief Scientific Officer · May 4, 2022 – Mar 20, 2023 · Past |
| Lou Cherico | Senior Vice President, Finance & Treasury · Since at least Nov 5, 2026 |
| Richard Aranda | Chief Medical Officer · Since at least Jun 21, 2021 |
| Robert Paul Smith Jr | Chief Commercial Officer · Since at least Dec 4, 2023 |
| Rob Roscigno | Senior Vice President of Clinical Development, Pulmonary Vascular Disease · Since at least Nov 5, 2026 |
| Skye Drynan | Director · Since at least Mar 11, 2024 |
| Steven D Nathan | Director · Since at least Mar 11, 2024 |
| Steven D. Nathan | Director · Since at least Nov 4, 2026 |